Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
12/2005
12/13/2005US6974791 These peptides possess a charge motif of positive-positive-hydrophobic which is important in determining the specificity of binding to tumor-derived endothelium.
12/13/2005CA2090634C Novel cyclosporins
12/08/2005WO2005116656A1 Identification of compounds modifying a cellular response
12/08/2005WO2005116643A2 Identification of compounds modifying a cellular response
12/08/2005WO2005116068A1 Peptides or peptidic conjugate derivatives of msh and the use thereof for cosmetically fighting against canities
12/08/2005WO2005116066A1 Peptides derived from decorin leucine rich repeats and uses thereof
12/08/2005WO2005116058A1 Peptides useful for treating gnrh associated diseases
12/08/2005WO2005116057A1 Monoclonal antibody against abca1
12/08/2005WO2005116056A1 Hla-a24- or hla-a2-binding peptide of parathyroid hormone-related protein
12/08/2005WO2005116055A1 Peptides, antibodies and compositions containing same useful for treating hiv virus infection
12/08/2005WO2005116053A1 Novel hair growth stimulant
12/08/2005WO2005116051A2 Tumor-associated peptides that bind to mhc-molecules
12/08/2005WO2005115174A2 Alpha-msh-antagonist didpeptide conjugates
12/08/2005WO2005115097A2 Cyclic peptide antibiotics
12/08/2005WO2005097828A3 Peptides of cav2.2 that inhibit pain
12/08/2005WO2005093069A3 Production of mersacidin and its variants in sigh and/or mrsa negative bacillus host cells
12/08/2005WO2005087261A3 Identification of self and non-self antigens implicated in autoimmune diseases
12/08/2005WO2005075448A3 A method for manufacturing optically pure coumaryl amino acids salts and the coumaryl amino acid salts thus obtained
12/08/2005WO2005041882A3 Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs
12/08/2005WO2005037859A3 Fluorescence assay for kinase activity
12/08/2005US20050272919 Immunoaffinity chromatography using epitope tags to polyol-responsive monoclonal antibodies
12/08/2005US20050272798 Analogues of rachelmycin and the duocarmycins that are potent cytotoxins containing a benzodipyrrole or naphthopyrrole ring; anticancer agents
12/08/2005US20050272663 Novel substituted prolines as inhibitors of hepatitis C virus NS3 serine protease
12/08/2005US20050272662 Self-assembled peptide-amphiphiles & self-assembled peptide nanofiber networks presenting multiple signals
12/08/2005US20050272661 providing a neo-tryptophan derivative, andlinking amino acid residues to said neo-tryptophan derivative to form neurotensin polypeptide containing neo-tryptophan
12/08/2005US20050272659 Helical peptidomimetics with enhanced activity
12/08/2005US20050272646 Cyclic peptide antibiotic wherein antibiotic is a streptogramin Type B derivative and is characterized by the replacement of an enzyme sensitive ester bond with a stable bond selected from an amide, N-methyl amide, enamine and sulfonamide bond
12/08/2005US20050272645 Isolated polypeptide; nonhemolytic, minimal in vitro cytotoxicity
12/08/2005US20050272078 Peptic nucleic acid probes for analysis of Enterococcus faecium
12/08/2005US20050271715 Conjugate having a cleavable linkage for use in a liposome
12/08/2005US20050271678 Diagnostic compositions containing the polypeptide conjugated to a detectable label, such as radioisotopes, enzymes, fluorescent labels, antibody conjugates, or substrates
12/08/2005CA2777821A1 Mhc molecule-binding tumor-associated peptides
12/08/2005CA2609558A1 Identification of compounds modifying a cellular response
12/08/2005CA2568254A1 Tumor-associated peptides that bind to mhc-molecules
12/08/2005CA2568168A1 Identification of compounds modifying a cellular response
12/08/2005CA2567942A1 Hla-a24- or hla-a2-binding peptide of parathyroid hormone-related protein
12/08/2005CA2566481A1 Peptides or peptidic conjugate derivatives of msh and the use thereof for cosmetically fighting against canities
12/08/2005CA2566478A1 Alpha-msh-antagonist didpeptide conjugates
12/07/2005EP1602931A1 SR-A antagonists
12/07/2005EP1602726A2 Human tachykinin-related splice variants and compositions thereof
12/07/2005EP1602719A1 Control of transglutaminase catalyzed protein modification by selective irreversible transglutaminase inhibitors
12/07/2005EP1601974A2 Differential megaplex immunoassay
12/07/2005EP1601766A1 Methods of constructing biodiverse gene fragment libraries and biological modulators isolated therefrom
12/07/2005EP1601684A2 Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease
12/07/2005EP1601384A1 Methods of radiofluorination of biologically active vectors
12/07/2005EP1601373A2 Intracellular delivery of small molecules proteins and nucleic acids
12/07/2005EP1601372A2 Clk-peptide and slk-peptide
12/07/2005EP1513874A4 Compositions and methods of use for a bombesin peptide
12/07/2005CN1705677A Anti-tumour compound
12/07/2005CN1704431A Melittin and use thereof
12/07/2005CN1704430A Process for preparing thymopentin
12/07/2005CN1704406A Intermediate for the preparation of epimino
12/07/2005CN1230535C Isolated peptides which form complexes with MHC molecule HLA-C-Clone 10 and uses thereof
12/07/2005CN1230443C Radio-labeled compound for imaging of thrombus
12/07/2005CN1230442C GnRh antagonists being modified in positions 5 and 6
12/07/2005CN1230441C Integrin binding peptide derivatives
12/06/2005US6972193 dimerization or oligomerization of intracellular proteins to activate genetic transcription; signal transduction and activators of transcription
12/06/2005CA2362834C Modulators of beta-amyloid peptide aggregation comprising d-amino acids
12/01/2005WO2005113792A1 Probe for detection/determination of inositol-1,4,5-triphosphoric acid and method of detecting/determining inositol-1,4,5-triphosphoric acid with the same
12/01/2005WO2005113582A1 Substituted ethane-1,2-diamines for the treatment of alzheimer's disease
12/01/2005WO2005113581A1 Substituted prolines as inhibitors of hepatitis c virus ns3 serine protease
12/01/2005WO2005077969A3 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
12/01/2005WO2005058938A3 Helical synthetic peptides that stimulate cellular cholesterol efflux
12/01/2005WO2004082629A3 Novel cyclosporins
12/01/2005US20050267294 Antibodies with increased affinities for anthrax antigens
12/01/2005US20050267291 Kinase mimic catalysts for asymmetric synthesis of phosphorylated inositols and cycloalkanols
12/01/2005US20050267039 IL-16 antagonists
12/01/2005US20050267036 Peptide sequence derived from the C-terminus of CaV2.2. and inhibits the interaction of CaV2.2 with Mint1-PDZ1, a glutathione S transferase fusion protein; neurotransmitter-release angonists of CaV2.2, the pore-forming subunit of N-type of voltage-dependent calcium channels; antinocciceptive agents
12/01/2005US20050267030 Use of deltaPKC peptides for modulation of reactive oxygen species
12/01/2005US20050267020 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same
12/01/2005US20050267019 Echinocandin derivatives, their method of preparation and their application as anti-fungal agents
12/01/2005US20050267017 Conformationally constrained C-backbone cyclic peptides
12/01/2005US20050266575 Pharmacophores for nociceptin, methods of obtaining and using in screening for nociceptin mimics
12/01/2005US20050266521 Production method for iturin a and its homologues
12/01/2005US20050266520 Process for the synthesis of peptides
12/01/2005US20050266498 Method for screening biomolecule activity regulator
12/01/2005US20050265965 Modified cytokines for use in cancer therapy
12/01/2005CA2567650A1 A probe for detection and quantification of inositol-1,4,5-trisphosphateand a method for detecting and quantifying inositol-1,4,5-trisphosphate using the same
12/01/2005CA2566610A1 Substituted prolines as inhibitors of hepatitis c virus ns3 serine protease
11/2005
11/30/2005EP1600504A1 Control of transglutaminase catalyzed protein modification by selective irreversible transglutaminase inhibitors
11/30/2005EP1600457A1 Peptide derivatives having beta-secretase inhibitory activity
11/30/2005EP1599499A2 Periodic antimicrobial peptides
11/30/2005EP1599173A2 Synthetic single domain polypeptides mimicking apolipoprotein e and methods of use
11/30/2005EP1252179B1 High purity lipopeptides, lipopeptide micelles, processes for preparing same and pharmaceutical compositions containing them
11/30/2005EP1250351B1 Methods to identify ctl epitopes of hiv
11/30/2005EP1056771B1 Streptogramin derivatives, preparation method and compositions containing same
11/30/2005EP0891377B1 Inhibitor and stimulator of haematopoietic stem cell proliferation and uses thereof
11/30/2005EP0870828B1 Novel polypeptide originating from hemophilus paragallinarum and process for producing the same
11/30/2005CN1703428A Peptides modulating caspase activation
11/30/2005CN1229646C Catalytic anti-factor VIII allo-antibodies
11/24/2005WO2005111064A1 Cyclopeptide derivatives with anti-integrin activity
11/24/2005WO2005111063A1 Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agents
11/24/2005WO2005110497A1 Imaging of tumors and metastases using a gelatinase targeting peptide comprising the structure ctthwgftlc.
11/24/2005WO2005110456A2 T-cell death-inducing epitopes
11/24/2005WO2005110425A1 Polymer-based sustained release device
11/24/2005WO2005047511A3 Bacterial expression of protease inhibitors and variants thereof
11/24/2005WO2005046710A3 Tgf-beta binding and supported peptides
11/24/2005WO2005046709A3 Tgf - beta binding and supported peptides
11/24/2005US20050261473 Carboxy protection strategies for acidic c-terminal amino acids in chemical ligation of oligopeptides
11/24/2005US20050261472 Binding moieties for fibrin
1 ... 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 ... 423